Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
>0-<0,05
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
0,0015%
General Information
Version
2.1
Revision date
2023-10-26
Product name
Stahlite RDT liq
1.2.1 Relevant identified uses
Product for treatment of leather and other flexible material
Emergency telephone
+31416689111, +31416344441
Icons in SDS
Company Information
company name
Stahl Europe BV
e-mail address of the competent person responsible for the Safety Data Sheet
msds@stahl.com
GHS Information
Signal word
No signal word
Section 2
SECTION 2: Hazards identification
Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS]] Classification of the substance or mixture
Product definition
Mixture
Signal word
No signal word.
Hazard statements
No known significant effects or critical hazards.
Prevention
Not applicable.
Response
Not applicable.
Storage
Not applicable.
Disposal
Not applicable.
Supplemental label elements
Contains 1,2-benzisothiazol-3(2H)-one, reaction mass of 5-chloro-2- methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1), May produce an allergic reaction. Safety data sheet available on request.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with Not applicable. child-resistant fastenings
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria This mixture does not contain any substances that are assessed to be a PBT or a for PBT or vPvB vPvB in concentration of 0.1% or higher. according to Regulation
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Not classified. See Section 11 for more detailed information on health effects and symptoms.
